Literature DB >> 22280421

Genetics of hypertrophic and dilated cardiomyopathy.

Felix W Friedrich1, Lucie Carrier.   

Abstract

Cardiomyopathies are categorized as extrinsic, being caused by external factors, such as hypertension, ischemia, inflammation, valvular dysfunction, or as intrinsic, which correspond to myocardial diseases without identifiable external causes. These so called primary cardiomyopathies can be categorized in four main forms: hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular cardiomyopathy. Cardiomyopathies are diagnosed by clinical expression, echocardiography, electrocardiography, non-invasive imaging, and sometimes by cardiac catheterization to rule out external causes as ischemia. The two main forms of primary cardiomyopathies are the hypertrophic and dilated cardiomyopathies. Most of hypertrophic cardiomyopathy and 20-50% of dilated cardiomyopathy are familial showing a wide genetic and phenotypic heterogeneity. This review presents the current knowledge on the causative genes, molecular mechanisms and the genotype � phenotype relations of hypertrophic and dilated cardiomyopathies.

Entities:  

Mesh:

Year:  2012        PMID: 22280421     DOI: 10.2174/138920112804583041

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  14 in total

Review 1.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.

Authors:  Verena Behrens-Gawlik; Giulia Mearini; Christina Gedicke-Hornung; Pascale Richard; Lucie Carrier
Journal:  Pflugers Arch       Date:  2013-12-12       Impact factor: 3.657

3.  Myosin light chain phosphorylation to the rescue.

Authors:  Henk L Granzier; Pieter P de Tombe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-08       Impact factor: 11.205

4.  PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction.

Authors:  Emad Muhammad; Aviva Levitas; Sonia R Singh; Alex Braiman; Rivka Ofir; Sharon Etzion; Val C Sheffield; Yoram Etzion; Lucie Carrier; Ruti Parvari
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

Review 5.  Gene therapy strategies in the treatment of hypertrophic cardiomyopathy.

Authors:  Maksymilian Prondzynski; Giulia Mearini; Lucie Carrier
Journal:  Pflugers Arch       Date:  2018-07-03       Impact factor: 3.657

6.  Association between angiotensinogen M235T polymorphism and hypertrophic cardiomyopathy.

Authors:  Jia-Lu Yao; Si-Jia Sun; Ya-Feng Zhou; Lang-Biao Xu; Xiang-Jun Yang; Xiao-Dong Qian
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.

Authors:  Bodvaël Fraysse; Florian Weinberger; Sonya C Bardswell; Friederike Cuello; Nicolas Vignier; Birgit Geertz; Jutta Starbatty; Elisabeth Krämer; Catherine Coirault; Thomas Eschenhagen; Jonathan C Kentish; Metin Avkiran; Lucie Carrier
Journal:  J Mol Cell Cardiol       Date:  2012-03-23       Impact factor: 5.000

8.  Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy.

Authors:  Giulia Mearini; Doreen Stimpel; Elisabeth Krämer; Birgit Geertz; Ingke Braren; Christina Gedicke-Hornung; Guillaume Précigout; Oliver J Müller; Hugo A Katus; Thomas Eschenhagen; Thomas Voit; Luis Garcia; Stéphanie Lorain; Lucie Carrier
Journal:  Mol Ther Nucleic Acids       Date:  2013-07-02       Impact factor: 10.183

Review 9.  Clinical and molecular classification of cardiomyopathies.

Authors:  Franco Cecchi; Benedetta Tomberli; Iacopo Olivotto
Journal:  Glob Cardiol Sci Pract       Date:  2012-07-03

10.  Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection.

Authors:  Robert F Miller; Juan P Kaski; James Hakim; Jonathan Matenga; Kusum Nathoo; Shungu Munyati; Sujal R Desai; Elizabeth L Corbett; Rashida A Ferrand
Journal:  Clin Infect Dis       Date:  2012-10-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.